Related Experiment Video
Updated: Sep 22, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Dual-Role of Cholesterol-25-Hydroxylase in Regulating Hepatitis B Virus Infection and Replication
Qi Wei1,2, Hongxiao Song1, Yanli Gao3
1Center for Pathogen Biology and Infectious Diseases, Department of Immunology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, the First Hospital of Jilin University, Changchun, Jilin, China.
Insights
Cholesterol-25-hydroxylase (CH25H) expression is elevated in Hepatitis B virus (HBV) patients and inhibits HBV replication by interacting with HBx protein. This interaction blocks HBx nuclear translocation, revealing a novel host-virus crosstalk mechanism.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Hepatitis B virus (HBV) causes millions of infections globally, posing a significant health challenge.
- Cholesterol-25-hydroxylase (CH25H) and its product 25-hydroxycholesterol (25HC) show broad-spectrum antiviral activity, but their role in HBV is unknown.
- Understanding host-virus interactions is crucial for developing effective HBV treatments.
Purpose of the Study:
- To investigate the role of CH25H in regulating HBV infection and replication.
- To identify CH25H mutants with retained antiviral activity but lacking hydroxylase function.
- To elucidate the molecular mechanism of CH25H-mediated regulation of HBV.
Main Methods:
- Compared CH25H expression in HBV-infected patients and healthy subjects.
- Generated and analyzed CH25H mutants for antiviral activity and interaction with HBx.
- Assessed the effect of CH25H and its mutants on HBx nuclear translocation and HBV replication.
Main Results:
- CH25H expression was increased in HBV-infected patients and inversely correlated with HBV replication.
- CH25H and its mutants interacted with HBx, inhibiting its nuclear translocation.
- CH25H's interaction with HBx's C-terminal region and CH25H's transmembrane region 3 were critical for inhibiting HBV replication, independent of enzymatic activity.
- 25HC promoted HBV infection but not replication.
Conclusions:
- CH25H plays a dual role in regulating HBV, inhibiting replication via HBx interaction independently of its enzymatic activity.
- The CH25H-HBx axis represents a novel host-virus crosstalk mechanism in HBV infection.
- CH25H and its mutants are potential therapeutic targets for controlling HBV replication.
Abstract:
Hepatitis B virus (HBV)-related diseases are among the major diseases that affect millions of people worldwide. These diseases are difficult to eradicate and thus pose a serious global health challenge. There is an urgent need to understand the cross talk mechanism between HBV and the host. Cholesterol-25-hydroxylase (CH25H) and its enzymatic product, 25-hydroxycholesterol (25HC), were previously shown to exhibit effective broad-spectrum antiviral activity. However, the role of CH25H in the regulation of HBV infection and replication remains unclear. The present study reported increased expression of CH25H in HBV-infected patients compared to healthy subjects. Importantly, higher expression of CH25H expression was found to be associated with low HBV replication. Additionally, the present study aimed to identify CH25H mutants, which would lack hydroxylase activity but retain antiviral activity toward HBV infection and replication. Interestingly, it was observed that both CH25H and its mutants interacted with HBx protein and inhibited nuclear translocation of HBx. In particular, CH25H interacted with the C-terminal region of HBx, while transmembrane region 3 of CH25H was found to be critical for CH25H-HBx interaction and inhibition of HBV replication. The study results suggested that 25HC promoted HBV infection but not HBV replication. Thus, the results of the present study suggested the involvement of a dual mechanism in CH25H-mediated regulation of HBV replication. The study clearly demonstrated cross talk between HBV and the host through CH25H-HBx axis. IMPORTANCE The enzymatic product of CH25H, 25-hydroxycholesterol (25HC), has been previously shown to play a critical role in the blockage of the cell-virus fusion in response to viral infection. However, our study indicates a dual role of CH25H in regulating HBV. We find the CH25H-mediated inhibition of HBV replication is independent on its enzyme activity and CH25H binds to HBx and inhibits HBx nucleus translocation. We are interested to find out 25HC promotes HBV infection.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Viruses with RNA Genomes
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Excretion: Influencing Factors
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

